FDA Inspection
Genzyme Ireland LimitedGenzyme Ireland Limited – FDA Inspection, Jan 20, 2026
Record Details
This FDA Inspection record concerns Genzyme Ireland Limited, with an inspection on January 20, 2026, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · 11ca1183-4f70-4146-abc3-2ba41b06fb88
Inspection Facts
- Inspection number
- 1301880
- FDA center
- Biologics
Other FDA inspections of Genzyme Ireland Limited
11| Date | Classification | Office | Project area |
|---|---|---|---|
| January 17, 2025 | Not classified | Office of Inspections and Investigations | |
| February 25, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 5, 2018 | Not classified | Office of Inspections and Investigations | |
| February 16, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 16, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Genzyme Ireland Limited
- FDA Inspection 1260340 - 2025-01-17
- FDA Inspection 1174738 - 2022-02-25
- FDA Inspection 1074857 - 2018-12-05
- FDA Inspection 1050839 - 2018-02-16
- FDA Inspection 1015545 - 2017-06-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.